mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.7 |
mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.7 |
mRNA |
NG-25 |
GDSC1000 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
0.023 |
0.7 |